
HT Capital
Asia, Beijing, China, Beijing'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Asset Management, Venture Capital, Fund of Funds
Investor Profile
HT Capital has made 12 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Series B (33%)
- Series C (25%)
- Series Unknown (17%)
- Series A (17%)
- Series D (8%)
Country Focus
- United States (50%)
- China (33%)
- Japan (8%)
- Israel (8%)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Autonomous Vehicles
- Manufacturing
- Biopharma
- Therapeutics
- Pharmaceutical
- Commercial
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.